Suppr超能文献

去酰胺化干扰素-β 变异体与整合素 αvβ3 结合。

A deamidated interferon-β variant binds to integrin αvβ3.

机构信息

Biotech Development Programme, CMC Science & Intelligence, Merck Serono S.p.A. (an affiliate of Merck KGaA, Darmstadt, Germany), Via Luigi Einaudi, 11, 00012 Guidonia Montecelio (Roma), Italy.

Pharmaceutical & Analytical Development Biotech Products, Merck Serono S.p.A. (an affiliate of Merck KGaA, Darmstadt, Germany), Via Luigi Einaudi, 11, 00012 Guidonia Montecelio (Roma), Italy.

出版信息

Cytokine. 2018 Apr;104:38-41. doi: 10.1016/j.cyto.2018.01.024. Epub 2018 Feb 6.

Abstract

Human type I interferons are a family of pleiotropic cytokines with antiviral, anti-proliferative and immunomodulatory activities. They signal through the same cell surface receptors IFNAR1 and IFNAR2 yet evoking markedly different physiological effects. One differentiating factor of interferon-beta (IFN-β) from other type I interferons is the presence of theAsn-Gly-Arg (NGR) sequence motif, which, upon deamidation, converts to Asp-Gly-Arg (DGR) and iso-Asp-Gly-Arg (iso-DGR) motifs. In other proteins, the NGR and iso-DGR motifs are reported as CD13- and αvβ3, αvβ5, αvβ6, αvβ8 and α5β1 integrin-binding motifs, respectively. The scope of this study was to perform exploratory surface plasmon resonance (SPR) experiments to assess the binding properties of a deamidated IFN-β variant to integrins. For this purpose, integrin αvβ3 was selected as a reference model within the iso-DGR- integrin binding members. The obtained results show that deamidated IFN-β binds integrin αvβ3 with nanomolar affinity and that the response was dependent on the deamidation extent. Based on these results, it can be expected that deamidated IFN-β also binds to other integrin family members that are able to bind to the iso-DGR binding motif. The novel binding properties could help elucidate specific IFN-β attributes that under physiological conditions may be modulated by the deamidation.

摘要

人Ⅰ型干扰素是一类具有抗病毒、抗增殖和免疫调节活性的多功能细胞因子。它们通过相同的细胞表面受体 IFNAR1 和 IFNAR2 信号传导,但引起明显不同的生理效应。干扰素-β(IFN-β)与其他Ⅰ型干扰素的一个区别因素是存在 Asn-Gly-Arg(NGR)序列基序,该基序在脱酰胺作用后转化为 Asp-Gly-Arg(DGR)和异 Asp-Gly-Arg(iso-DGR)基序。在其他蛋白质中,NGR 和 iso-DGR 基序分别被报道为 CD13 和 αvβ3、αvβ5、αvβ6、αvβ8 和 α5β1 整合素结合基序。本研究的目的是进行探索性表面等离子体共振(SPR)实验,以评估去酰胺 IFN-β 变体与整合素的结合特性。为此,选择整合素 αvβ3 作为 iso-DGR-整合素结合成员中的参考模型。获得的结果表明,去酰胺 IFN-β 以纳摩尔亲和力结合整合素 αvβ3,并且该响应取决于脱酰胺程度。基于这些结果,可以预期去酰胺 IFN-β 也结合能够与 iso-DGR 结合基序结合的其他整合素家族成员。新的结合特性可以帮助阐明在生理条件下可能被脱酰胺修饰调节的特定 IFN-β 属性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验